{"id":9852,"date":"2026-07-10T16:57:35","date_gmt":"2026-07-10T15:57:35","guid":{"rendered":"https:\/\/savvy-career.com\/?p=9852"},"modified":"2026-07-11T02:45:27","modified_gmt":"2026-07-11T01:45:27","slug":"pharma-hr-barometer","status":"publish","type":"post","link":"https:\/\/savvy-career.com\/fr\/pharma-hr-barometer\/","title":{"rendered":"Pharma HR Barometer"},"content":{"rendered":"<section class=\"pharma-cv-article\" style=\"max-width: 900px; margin: 0 auto; padding: 40px 20px; font-family: Arial, Helvetica, sans-serif; font-size: 17px; line-height: 1.7; color: #1f2937; font-weight: 400;\">\n<header style=\"margin-bottom: 30px;\">\n<h1 style=\"font-size: 36px; line-height: 1.2; margin: 0 0 15px; color: #111827; font-weight: bold;\">The Pharma Human-Capital Barometer: what Algeria&#8217;s numbers really say about talent<\/h1>\n<p style=\"font-size: 17px; color: #4b5563; margin: 0;\">Behind the headline production figures lies a fast-tightening labour market. We compiled the verifiable industry data and read it through a human-capital lens, including the one number nobody officially publishes.<\/p>\n<\/header>\n<nav style=\"background: #f8fafc; border: 1px solid #e5e7eb; border-radius: 12px; padding: 20px; margin-bottom: 40px;\">\n<h2 style=\"font-size: 22px; margin: 0 0 15px; color: #111827; font-weight: bold;\">In this barometer<\/h2>\n<ol style=\"margin: 0; padding-left: 20px;\">\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#snapshot\">The sector at a glance<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#reading\">Reading the numbers as a talent story<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#gap\">The missing metric: sector employment<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#pressure\">Where the hiring pressure concentrates<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#takeaway\">\u00c0 retenir<\/a><\/li>\n<li><a style=\"color: #0f766e; text-decoration: none;\" href=\"#sources\">Sources &amp; methodology<\/a><\/li>\n<\/ol>\n<\/nav>\n<article>\n<section id=\"snapshot\" style=\"margin-bottom: 40px;\">\n<h2 style=\"font-size: 28px; margin: 0 0 15px; color: #111827; font-weight: bold;\">The sector at a glance<\/h2>\n<p style=\"margin: 0 0 20px;\">The figures below are drawn from Algerian government statements and industry press through late 2025. Where official sources differ, we show the range rather than a single number.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(2, 1fr); gap: 16px; margin: 0 0 8px;\">\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 20px;\">\n<p style=\"font-size: 40px; font-weight: bold; color: #0f766e; margin: 0;\">~218<\/p>\n<p style=\"font-size: 15px; color: #4b5563; margin: 6px 0 0;\">production plants, about <strong>30% of Africa&#8217;s<\/strong> pharma industry (Ministry, May 2025)<\/p>\n<\/div>\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 20px;\">\n<p style=\"font-size: 40px; font-weight: bold; color: #0f766e; margin: 0;\">~80%+<\/p>\n<p style=\"font-size: 15px; color: #4b5563; margin: 6px 0 0;\">of national needs met locally, officials cite <strong>79% to 83%<\/strong> in 2025, up from ~70% in 2024<\/p>\n<\/div>\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 20px;\">\n<p style=\"font-size: 40px; font-weight: bold; color: #0f766e; margin: 0;\">&gt;$4B<\/p>\n<p style=\"font-size: 15px; color: #4b5563; margin: 6px 0 0;\">expected local production value in 2024, from <strong>$3.14B (2022)<\/strong> and $3.56B (2023)<\/p>\n<\/div>\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 20px;\">\n<p style=\"font-size: 40px; font-weight: bold; color: #0f766e; margin: 0;\">780+<\/p>\n<p style=\"font-size: 15px; color: #4b5563; margin: 6px 0 0;\">production lines nationwide, spanning multiple therapeutic classes<\/p>\n<\/div>\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 20px;\">\n<p style=\"font-size: 40px; font-weight: bold; color: #0f766e; margin: 0;\">3,400+<\/p>\n<p style=\"font-size: 15px; color: #4b5563; margin: 6px 0 0;\">molecules produced locally, of ~4,500 on the national market<\/p>\n<\/div>\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 20px;\">\n<p style=\"font-size: 40px; font-weight: bold; color: #0f766e; margin: 0;\">103<\/p>\n<p style=\"font-size: 15px; color: #4b5563; margin: 6px 0 0;\">new investment projects under review, <strong>72 medicines, 31 medical devices<\/strong> (late 2025)<\/p>\n<\/div>\n<\/div>\n<p style=\"font-size: 14px; color: #6b7280; margin: 14px 0 0; font-style: italic;\">Note: plant counts vary by source and definition, official statements cite figures from ~203 to ~233 pharmaceutical establishments depending on date and scope.<\/p>\n<\/section>\n<section id=\"reading\" style=\"margin-bottom: 40px;\">\n<h2 style=\"font-size: 28px; margin: 0 0 15px; color: #111827; font-weight: bold;\">Reading the numbers as a talent story<\/h2>\n<p style=\"margin: 0 0 16px;\">Each of these figures is, underneath, a workforce figure. A jump from $3.14B to over $4B in production in two years does not happen without people to run the lines, release the batches and file the dossiers. More than 780 production lines require qualified operators, maintenance engineers and QC analysts. Producing 3,400+ molecules, including increasingly complex ones, demands regulatory and quality expertise at scale.<\/p>\n<p style=\"margin: 0 0 16px;\">The most telling indicator is the pipeline: 103 investment projects under study, with 72 in medicines. Each new unit that comes online will need a full technical team before it can release a single batch. In other words, the demand curve for specialized talent is set to steepen well before the supply of experienced professionals can catch up.<\/p>\n<div style=\"background: #f0fdf4; border-left: 4px solid #16a34a; padding: 18px; border-radius: 8px; margin-top: 20px;\">\n<p style=\"margin: 0;\"><strong>The signal:<\/strong> import substitution has moved faster than talent formation. The bottleneck is shifting from capital to competence.<\/p>\n<\/div>\n<\/section>\n<section id=\"gap\" style=\"margin-bottom: 40px;\">\n<h2 style=\"font-size: 28px; margin: 0 0 15px; color: #111827; font-weight: bold;\">The missing metric: sector employment<\/h2>\n<p style=\"margin: 0 0 16px;\">Here is the honest limit of any Algerian pharma HR barometer today: there is no single, regularly published, consolidated figure for total employment across the pharmaceutical industry. Official communication is rich on plants, coverage rates and production value, and comparatively silent on headcount, role mix, vacancy rates or time-to-fill.<\/p>\n<p style=\"margin: 0 0 16px;\">That gap is itself a finding. For a sector positioned as strategic to health sovereignty, the absence of standardized human-capital data makes workforce planning harder for everyone, public authorities, employers and universities alike. Any headcount figure circulating without a clear, dated official source should be treated with caution rather than repeated as fact.<\/p>\n<div style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 24px; margin-top: 20px;\">\n<h3 style=\"font-size: 22px; margin: 0 0 12px; color: #0f172a; font-weight: bold;\">A barometer is only as honest as its gaps<\/h3>\n<p style=\"margin: 0;\">We report what is verifiable, flag what is not, and resist filling the void with a convenient number.<\/p>\n<\/div>\n<\/section>\n<section id=\"pressure\" style=\"margin-bottom: 40px;\">\n<h2 style=\"font-size: 28px; margin: 0 0 15px; color: #111827; font-weight: bold;\">Where the hiring pressure concentrates<\/h2>\n<p style=\"margin: 0 0 16px;\">Reading the industry&#8217;s own priorities, local raw-material production launching from 2025, biosimilars manufacturing on the agenda of the 9th National Pharmacy Congress (December 2025), and a wave of new units, points to where demand is most acute:<\/p>\n<ul style=\"padding-left: 22px; margin: 0;\">\n<li style=\"margin-bottom: 8px;\"><strong>Quality assurance &amp; regulatory affairs<\/strong>, the compliance backbone of every new line<\/li>\n<li style=\"margin-bottom: 8px;\"><strong>Process &amp; industrial pharmacists<\/strong>, validation, scale-up and GMP operations<\/li>\n<li style=\"margin-bottom: 8px;\"><strong>Maintenance &amp; automation engineers<\/strong>, to keep 780+ lines running<\/li>\n<li style=\"margin-bottom: 8px;\"><strong>Bioproduction specialists<\/strong>, as biosimilars and complex products expand<\/li>\n<li>Analytical chemists for QC laboratories and raw-material control<\/li>\n<\/ul>\n<\/section>\n<section id=\"takeaway\" style=\"background: #ecfeff; border: 1px solid #a5f3fc; border-radius: 12px; padding: 24px; margin-top: 0; margin-bottom: 40px;\">\n<h2 style=\"font-size: 24px; margin: 0 0 12px; color: #0f172a; font-weight: bold;\">\u00c0 retenir<\/h2>\n<p style=\"margin: 0;\">Algeria&#8217;s pharmaceutical numbers tell a clear human-capital story: production, coverage and investment are climbing fast, and every point of growth deepens the need for specialized talent. Yet the industry lacks consolidated employment data, the very metric HR strategy depends on. Employers who track their own workforce indicators, invest early in training, and source through specialized channels will navigate the tightening market far better than those flying blind.<\/p>\n<\/section>\n<section id=\"sources\" style=\"margin-bottom: 10px;\">\n<h2 style=\"font-size: 24px; margin: 0 0 12px; color: #111827; font-weight: bold;\">Sources &amp; methodology<\/h2>\n<p style=\"margin: 0 0 12px; font-size: 15px; color: #4b5563;\">Figures reflect Algerian government statements and industry press through late 2025. Ranges are shown where official sources differ. No consolidated official sector-employment figure was available at the time of writing.<\/p>\n<ul style=\"padding-left: 22px; margin: 0; font-size: 15px; color: #4b5563;\">\n<li style=\"margin-bottom: 6px;\">Maghreb Pharma Expo, &#8220;With 218 plants, Algeria accounts for 30% of Africa&#8217;s pharmaceutical industry&#8221; (May 2025)<\/li>\n<li style=\"margin-bottom: 6px;\">APS \/ Alg\u00e9rie \u00c9co, pharmaceutical production expected to exceed $4 billion in 2024<\/li>\n<li style=\"margin-bottom: 6px;\">DzairTube \/ ElDjazair Today, over 80% of national demand met by local production (2025)<\/li>\n<li style=\"margin-bottom: 6px;\">Radio Alg\u00e9rienne, evolution of the sector and national production units<\/li>\n<li style=\"margin-bottom: 6px;\">Maghreb Info, 103 new investment projects (72 medicines, 31 medical devices), late 2025<\/li>\n<li style=\"margin-bottom: 6px;\">L&#8217;Alg\u00e9rie Aujourd&#8217;hui, medicine imports down from $1.25B (2022) to $515M (2024)<\/li>\n<li>F\u00e9d\u00e9ration Alg\u00e9rienne de Pharmacie, 9th National Congress (18-20 Dec 2025), biosimilars manufacturing on the agenda<\/li>\n<\/ul>\n<\/section>\n<\/article>\n<\/section>\n<section class=\"pharma-cv-article\" style=\"max-width: 900px; margin: 0 auto; padding: 40px 20px; font-family: Arial, Helvetica, sans-serif; font-size: 17px; line-height: 1.7; color: #1f2937; font-weight: 400;\">\n<header style=\"margin-bottom: 30px;\">\n<p style=\"font-size: 14px; font-weight: bold; text-transform: uppercase; color: #0f766e; letter-spacing: 0.5px; margin: 0 0 10px;\">Barom\u00e8tre RH Pharma \u2022 Alg\u00e9rie \u2022 \u00e9dition 2026<\/p>\n<h1 style=\"font-size: 36px; line-height: 1.2; margin: 0 0 15px; color: #111827; font-weight: bold;\">Le Barom\u00e8tre du capital humain pharma : ce que les chiffres de l&#8217;Alg\u00e9rie disent vraiment des talents<\/h1>\n<p style=\"font-size: 17px; color: #4b5563; margin: 0;\">Derri\u00e8re les chiffres de production se cache un march\u00e9 du travail qui se tend rapidement. Nous avons compil\u00e9 les donn\u00e9es v\u00e9rifiables du secteur et les avons lues sous l&#8217;angle du capital humain, y compris le seul chiffre que personne ne publie officiellement.<\/p>\n<\/header>\n<nav style=\"background: #f8fafc; border: 1px solid #e5e7eb; border-radius: 12px; padding: 20px; margin-bottom: 40px;\">\n<h2 style=\"font-size: 22px; margin: 0 0 15px; color: #111827; font-weight: bold;\">Dans ce barom\u00e8tre<\/h2>\n<ol style=\"margin: 0; padding-left: 20px;\">\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#snapshot\">Le secteur en un coup d&#8217;\u0153il<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#reading\">Lire les chiffres comme une histoire de talents<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#gap\">La donn\u00e9e manquante : l&#8217;emploi du secteur<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#pressure\">O\u00f9 se concentre la pression au recrutement<\/a><\/li>\n<li style=\"margin-bottom: 8px;\"><a style=\"color: #0f766e; text-decoration: none;\" href=\"#takeaway\">Ce qu&#8217;il faut retenir<\/a><\/li>\n<li><a style=\"color: #0f766e; text-decoration: none;\" href=\"#sources\">Sources &amp; m\u00e9thodologie<\/a><\/li>\n<\/ol>\n<\/nav>\n<article>\nceux qui avancent \u00e0 l&#8217;aveugle.<\/p>\n<\/section>\n<section id=\"sources\" style=\"margin-bottom: 10px;\">\n<h2 style=\"font-size: 24px; margin: 0 0 12px; color: #111827; font-weight: bold;\">Sources &amp; m\u00e9thodologie<\/h2>\n<p style=\"margin: 0 0 12px; font-size: 15px; color: #4b5563;\">Les chiffres refl\u00e8tent des d\u00e9clarations officielles alg\u00e9riennes et la presse sectorielle jusqu&#8217;\u00e0 fin 2025. Des fourchettes sont indiqu\u00e9es l\u00e0 o\u00f9 les sources divergent. Aucun chiffre officiel consolid\u00e9 sur l&#8217;emploi du secteur n&#8217;\u00e9tait disponible au moment de la r\u00e9daction.<\/p>\n<ul style=\"padding-left: 22px; margin: 0; font-size: 15px; color: #4b5563;\">\n<li style=\"margin-bottom: 6px;\">Maghreb Pharma Expo : \u00ab Avec 218 usines, l&#8217;Alg\u00e9rie repr\u00e9sente 30 % de l&#8217;industrie pharmaceutique africaine \u00bb (mai 2025)<\/li>\n<li style=\"margin-bottom: 6px;\">APS \/ Alg\u00e9rie \u00c9co : production pharmaceutique attendue \u00e0 plus de 4 milliards de dollars en 2024<\/li>\n<li style=\"margin-bottom: 6px;\">DzairTube \/ ElDjazair Today : plus de 80 % des besoins nationaux couverts par la production locale (2025)<\/li>\n<li style=\"margin-bottom: 6px;\">Radio Alg\u00e9rienne : \u00e9volution du secteur et unit\u00e9s de production nationales<\/li>\n<li style=\"margin-bottom: 6px;\">Maghreb Info : 103 nouveaux projets d&#8217;investissement (72 m\u00e9dicaments, 31 dispositifs m\u00e9dicaux), fin 2025<\/li>\n<li style=\"margin-bottom: 6px;\">L&#8217;Alg\u00e9rie Aujourd&#8217;hui : importations de m\u00e9dicaments en baisse, de 1,25 Md$ (2022) \u00e0 515 M$ (2024)<\/li>\n<li>F\u00e9d\u00e9ration Alg\u00e9rienne de Pharmacie : 9e Congr\u00e8s national (18-20 d\u00e9c. 2025), fabrication de biosimilaires \u00e0 l&#8217;ordre du jour<\/li>\n<\/ul>\n<\/section>\n<\/article>\n<\/section>","protected":false},"excerpt":{"rendered":"<p>The Pharma Human-Capital Barometer: what Algeria&#8217;s numbers really say about talent Behind the headline production figures lies a fast-tightening labour market. We compiled the verifiable industry data and read it&#8230;<\/p>","protected":false},"author":1,"featured_media":9853,"comment_status":"open","ping_status":"closed","sticky":false,"template":"Savvy Expert Article Template.php","format":"standard","meta":{"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[682,679,680],"tags":[],"class_list":["post-9852","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-barometre-de-lemploi","category-career-path","category-talent-management"],"_links":{"self":[{"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/posts\/9852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/comments?post=9852"}],"version-history":[{"count":0,"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/posts\/9852\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/media\/9853"}],"wp:attachment":[{"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/media?parent=9852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/categories?post=9852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/savvy-career.com\/fr\/wp-json\/wp\/v2\/tags?post=9852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}